Gamgee Personalized mRNA Cancer Vaccine for Dogs
Provider 
Founded 2026
Sells To Individuals
Pricing Model Pre-Revenue
Ownership Private

A personalized mRNA cancer vaccine for dogs, designed from each dog's own tumour and matched healthy DNA.
Gamgee designs a therapeutic personalized mRNA cancer vaccine for dogs that already have cancer. Tumour tissue and a matched normal sample are sequenced, the mutations present in the tumour but absent from healthy cells are ranked as candidate neoantigens, and the selected targets are encoded into a patient-specific mRNA construct that is manufactured and delivered to the treating clinic with a dosing schedule.
The offering is investigational and is delivered through an Australian clinical trial currently limited to mast cell tumour and osteosarcoma, and through a referral and case-management service for veterinary clinics.
Elias Animal Health

ELIAS Cancer Immunotherapy (ECI)
RosieVaccine

RosieVaccine Personalized mRNA Cancer Vaccine for Dogs
Torigen Pharmaceuticals

Torigen VimClara Autologous Cancer Vaccine Kit
| Attribute | Gamgee Personalized mRNA Cancer Vaccine for Dogs | ELIAS Cancer Immunotherapy (ECI) | RosieVaccine Personalized mRNA Cancer Vaccine for Dogs | Torigen VimClara Autologous Cancer Vaccine Kit | |
|---|---|---|---|---|---|
| Provider | |||||
| Founded | 2026 | 2014 | — | — | |
| Sells To | Individuals | Enterprise, Small Business | — | — | |
| Pricing Model | Pre-Revenue | Recurring, Software | — | — | |
| Ownership | Private | Venture-backed | — | — |
Provider 
Founded 2026
Sells To Individuals
Pricing Model Pre-Revenue
Ownership Private
Provider 
Founded 2014
Sells To Enterprise, Small Business
Pricing Model Recurring, Software
Ownership Venture-backed
Provider 
Founded —
Sells To —
Pricing Model —
Ownership —
Provider 
Founded —
Sells To —
Pricing Model —
Ownership —